Golden Road Advisors LLC Sells 231 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Golden Road Advisors LLC decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 36.8% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 397 shares of the healthcare conglomerate’s stock after selling 231 shares during the quarter. Golden Road Advisors LLC’s holdings in UnitedHealth Group were worth $232,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Principal Securities Inc. boosted its holdings in shares of UnitedHealth Group by 8.9% in the third quarter. Principal Securities Inc. now owns 23,726 shares of the healthcare conglomerate’s stock worth $13,872,000 after acquiring an additional 1,933 shares during the period. Stephens Inc. AR lifted its holdings in shares of UnitedHealth Group by 1.3% in the third quarter. Stephens Inc. AR now owns 42,446 shares of the healthcare conglomerate’s stock worth $24,817,000 after buying an additional 525 shares in the last quarter. Lincluden Management Ltd. grew its stake in UnitedHealth Group by 1.3% during the third quarter. Lincluden Management Ltd. now owns 8,580 shares of the healthcare conglomerate’s stock valued at $5,017,000 after acquiring an additional 106 shares in the last quarter. Oak Ridge Investments LLC lifted its stake in UnitedHealth Group by 7.2% in the 3rd quarter. Oak Ridge Investments LLC now owns 39,719 shares of the healthcare conglomerate’s stock worth $23,223,000 after purchasing an additional 2,669 shares in the last quarter. Finally, Reston Wealth Management LLC purchased a new position in shares of UnitedHealth Group during the 3rd quarter valued at $119,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the company. Argus boosted their target price on UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. Truist Financial reaffirmed a “buy” rating and issued a $625.00 target price (down from $640.00) on shares of UnitedHealth Group in a research note on Wednesday, October 16th. Cantor Fitzgerald increased their price target on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a report on Wednesday, October 16th. HSBC lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 17th. Finally, Robert W. Baird lifted their price target on UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 17th. Four research analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average target price of $615.53.

UnitedHealth Group Stock Up 0.3 %

Shares of NYSE UNH opened at $564.40 on Friday. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $608.63. The company has a current ratio of 0.91, a quick ratio of 0.88 and a debt-to-equity ratio of 0.74. The firm has a fifty day simple moving average of $582.30 and a two-hundred day simple moving average of $540.65. The firm has a market capitalization of $521.18 billion, a PE ratio of 36.77, a price-to-earnings-growth ratio of 1.65 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. During the same quarter in the prior year, the business earned $6.56 EPS. The business’s revenue for the quarter was up 9.2% on a year-over-year basis. Equities analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.49%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s payout ratio is currently 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.